26 JUNE 2023

Vape: Why is the government ignoring its own data and evidence?

MOH has described the e-cigarettes and vape as a “public health threat”.

15 JUNE 2023

Health White Paper Presents Opportunity For Bold Healthcare Financing Reform

A more sustainable solution such as National Health Insurance should be proposed and supported.

19 APRIL 2023

Pharmaniaga Concession Renewal Decision Major Setback On Health Reforms

Seen as rewarding the company regardless of its performance or the risk it represents.

The Galen Centre for Health and Social Policy is an independent public policy research and advocacy organisation.

What do we think about key health and social issues?

12 JUNE 2023

Control of Smoking Product for Public Health Bill 2023: Failure Is Not an Option

Vape and e-cigarettes constitute clear and present public health threats.

1 APRIL 2023

Removal of Liquid, Gel Nicotine Under Poisons Act Is A Disastrous Move

This decision undermines and removes a cornerstone of anti-tobacco policy.

29 MARCH 2023

Proposal to Exclude Liquid or Gel Nicotine Under Poisons Act Is Against Public Health

Already, the nicotine content for vape products available in this country is among the highest in the world.

21 MARCH 2023

Dewan Rakyat Approval of Special Select Committee On Health Welcomed

The need for a PSSC on Health goes beyond providing oversight to and evaluation of the government's management of existing health concerns

17 MARCH 2023

100 Days of Unity Government: B Grade for Health

The Malaysian healthcare system and the health of people in this country are currently in crisis. Urgent action is needed.

1 MARCH 2023

Pharmaniaga Situation – Opportunity For Pharmaceutical Procurement Reform

Reforms include removing dependence on middlemen within the procurement process, which increase the cost of medicines.

Event Recordings

This session is Part 2 of the Health Economics for Rare Diseases Workshop previously held on 22 November. Prof. Rob Baltussen of Radboud Universiteit, Netherlands continues the conversation with a discussion on the use of multiple-criteria decision analysis for decision making on rare diseases. This session is Part 2 of the Health Economics for Rare Diseases Workshop previously held on 22 November. Prof. Rob Baltussen of Radboud Universiteit, Netherlands continues the conversation with a discussion on the use of multiple-criteria decision analysis for decision making on rare diseases. Speaker background Prof. Rob Baltussen is an economist specialized in global health economics. His research focuses on the development of methods and tools for priority setting in health, to support Ministries of Health to make socially acceptable choices. For this, Baltussen integrates methods from various disciplines such as economics, ethic and decisions, which resulted in the development of ‘evidence-informed deliberative processes’ (EDPs). He has also led the citizen forum on ‘Choices in health care’ which was held in the Netherlands in 2017. Presently, Baltussen and his team are supporting several Minisatries of Health around the world through the implementation of EDP, including in the Netherlands, Ghana, Indonesia, Iran, Kazachstan, Tanzania and Moldova. Baltussen was Chair of the International Society for Priorities in Health 2016-2018. He has extensive field work experience in around 25 countries in Africa and Asia, and worked as a senior health economist at the World Health Organization in Geneva being responsible for the development of WHO guidelines on cost-effectiveness analysis. Prof. Rob Baltussen is an economist specialized in global health economics. His research focuses on the development of methods and tools for priority setting in health, to support Ministries of Health to make socially acceptable choices. For this, Baltussen integrates methods from various disciplines such as economics, ethic and decisions, which resulted in the development of ‘evidence-informed deliberative processes’ (EDPs). He has also led the citizen forum on ‘Choices in health care’ which was held in the Netherlands in 2017. Presently, Baltussen and his team are supporting several Minisatries of Health around the world through the implementation of EDP, including in the Netherlands, Ghana, Indonesia, Iran, Kazachstan, Tanzania and Moldova. Baltussen was Chair of the International Society for Priorities in Health 2016-2018. He has extensive field work experience in around 25 countries in Africa and Asia, and worked as a senior health economist at the World Health Organization in Geneva being responsible for the development of WHO guidelines on cost-effectiveness analysis.
En. Syed Johari Syed Jamaludin, an ILD patient, shares his experience being diagnosed and treated for interstitial lung disease treatment, as well as the challenges faced throughout his journey. This presentation was part of the symposium "Interstitial Lung Disease in Malaysia: Addressing awareness, treatment and care, and unmet needs" organised by the Galen Centre of Health and Social Policy on 21 October 2022. Held with the support of Boehringer Ingelheim, the symposium discussed the state of care for interstitial lung disease (ILD) in Malaysia, as part of preparations to develop a White Paper on this condition.
Dr Noorul Afidza Muhammad, a pulmonologist with Hospital Serdang presents an update on clinical trials related to interstitial lung disease treatment. This presentation was part of the symposium "Interstitial Lung Disease in Malaysia: Addressing awareness, treatment and care, and unmet needs" organised by the Galen Centre of Health and Social Policy on 21 October 2022. Held with the support of Boehringer Ingelheim, the symposium discussed the state of care for interstitial lung disease (ILD) in Malaysia, as part of preparations to develop a White Paper on this condition.

Our Focus Areas

Healthcare Reform

We look at how institutional reforms can create an adaptive and sustainable healthcare system and social care, capable of delivering integrated models of care to meet the challenges of our developing society.

Non-Communicable Diseases

Non-communicable diseases (NCDs) are emerging as the leading cause of death in Malaysia. About two-thirds of Malaysians have at least one NCD. What policies and interventions are needed in response?

Food Security

We look at the linkages of food security with health, sustainable economic development, environment, social justice and trade.

 

 

Transgender Health

Transgender people face numerous health disparities, stigma, discrimination, and lack of access to quality care. How do medical institutions, communities and individuals respond to their care?